The renin angiotensin aldosterone system is an important regulator of the extracellular volume and of the control of blood pressure. It is mainly controlled in its activity by the rate of renin release from the kidney. Within the kidney renin is produced, stored and released from the so-called granular juxtaglomerular cells. These cells are modified smooth muscle cells and are found in the tunica media of the afferent arteriole, just adjacent to the glomerulus. They resemble morphologically vascular smooth muscle cells but have also characteristic features of secretory cells with respect to a welldeveloped endoplasmic reticulum, a prominent Golgi-apparatus and membrane bound granules containing renin [6, 73] .
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Since the rate of renin release from juxtaglomerular cells has a direct effect on blood pressure and because an enhanced rate of renin release is known to be a major reason of hypertension, the mechanisms controlling renal renin release have attracted considerable interest among physiologists, pharmacologists and clinicians.
So far four basic mechanisms controlling renin release from the kidney have been described [26] . These comprise 1. The intra-renal blood pressure, which influences renin release by an as yet undefined baroreceptor.
2. The amount of NaCl-load sensed by the macula densa segment of the distal tubule (macula densa sensor).
3. The sympathetic nervous system 4. A large number of humoral factors like catecholamines, angiotensin II, vasopressin, atrial natriuretic peptide as well as metabolites as for example adenosine.
In spite of the large body of findings about the modulation and alteration of renal renin release, the intracellular mechanisms by which renin release is controlled within the juxtaglomerular cells are not clearly understood.
During the last years the mechanisms of physiological and pharmacological alterations of renin release have been reviewed [26, 36, 39] . The present contribution wants to concentrate on the intracellular processes that influence renin release from juxtaglomerular cells. The available information will be discussed in front of the background of the present knowledge about the general mechanisms of secretion.
For a variety of secretory cells including adrenal medulla and cortex, pituitary, exocrine and endocrine pancreas, neutrophils and platelets it has been found that the secretory process is triggered by the intracellular levels of calcium and cyclic nucleotides and further by the activity of protein kinase C [12, 33, 64, 68, [70] [71] [72] . I shall therefore discuss in special the role of intracellular calcium, intracellular cyclic AMP and cyclic GMP and protein kinase C activity in the control of renin release from juxtaglomerular cells. In this context I will also present our own results obtained from studies on the intracellular control of renin release from isolated juxtaglomerular cells.
Role of Calcium in the Intracellular Control of Renin Release
The typical secretory process in a large number of secreting cells has been found to be biphasic. The secretory process in these cells is initiated by a high and short-termed rise in the intracellular calcium concentration. This initiation phase is then followed by a so-called sustained phase of secretion and this phase is considered to be maintained the activity of a protein kinase C. The rise in intracellular calcium and in consequence the initiation of secretion is brought about by two mechanisms. First, by an enhancement of the transmembrane calcium influx [42] from the extracellular into the intracellular space and second by the release of calcium from intracellular stores [41, 69] . In view of the importance of calcium for the normal secretory process it is obvious therefore to discuss the role of intracellular calcium in the control of renin release from juxtaglomerular cells.
Experimental evidence obtained from incubations with renal cortical slices and incubations with renal glomeruli clearly indicates that the rate of renin release is inversely related to the extracellular concentration of calcium [28, 30, 37, 40, 43, 81] . Assuming that the intracellular and the extracellular calcium concentration are correlated one would expect therefore that the releasing rate of renin is also inversely related to the intracellular concentration of calcium. However, as Churchill has pointed out [17] , the assumption of a direct correlation between the extracellular and the intracellular concentration of calcium is incorrect, and the inverse relationship between renin release and extracellular calcium concentration can only give supportive evidence for the role of calcium in the control of renin release. More information about the role of calcium in the intracellular regulation of renin release can be gained from experiments in which the calcium extrusion from the juxtaglomerular cells is blocked. Calcium extrusion from a cell in general is effected by two processes. First, by a sodium-calcium exchange mechanism [4] and second by an energy dependent calcium ATPase [4, 64] . The activity of the sodium-calcium exchange is driven by the sodium gradient from the extracellular to the intracellular space [8] . Since the sodium gradient between the extra-and the intracellular space is maintained by the activity of the sodium-potassium ATPase, the function of the sodium-calcium exchange is finally linked to the activity of the sodium-potassium ATPase. In consequence, inhibition of the sodium-potassium ATPase by ouabain blocks the sodium-calcium exchange. Therefore ouabain leads to an accumulation of calcium within the cell and in consequence to a rise in the intracellular calcium concentration. Ouabain has been found to inhibit renin release [14, 29, 49, 58, 59] and additional evidence was obtained to show that this inhibition is a calcium dependent process [14, 25, 58] . Inhibition of the calcium ATPase by vanadate also inhibits part of the extrusion of calcium and therefore leads to a rise in the intracellular calcium concentration [56] . Vanadate has also been found to inhibit renin release [18, 47] . These findings indicate that a rise of the intracellular calcium concentration inhibits the secretory process in the juxtaglomerular cells.
Moreover, it has been found that spontaneous renin release from whole kidneys, kidney slices, glomeruli and isolated juxtaglomerular cells is en- hanced by calcium entry blockers [1, 24] and inhibited by facilitation of calcium entry [20, 21, 27, 51] . In addition, hormones known to mobilize calcium in several tissues such as angiotensin II, vasopressin and norepinephrine have been found to inhibit renin release by a calcium dependent process [10, 16, 77, 79] . Using isolated juxtaglomerular cells, we could show that these hormones enhanced transmembrane calcium influx into the cells and led to a rise in the intracellular calcium concentration [45] . Furthermore we found that that renin release from the juxtaglomerular cells was inversely correlated to the transmembrane calcium influx ( Fig. 1 ). We and others have shown that the inhibitory effect of these agents could be attenuated or even be abolished by calcium channel blockers such as verapamil [15, 45, 59] . Taken together, all of the findings mentioned above are supportive of the idea that the rate of renin release from the juxtaglomerular cells is inversely related to the calcium concentration in the juxtaglomerular cells. In this regard renin secretion behaves strikingly different from the typical mechanism of secretion in which the secretion rate is directly correlated to the intracellular calcium concentration. The mechanism by which intracellular calcium inhibits the secretory process in juxtaglomerular cells is unknown.
Calcium dependent reactions are usually triggered by calcium in two ways, either by the action of ionized calcium or by calcium binding proteins such as calmodulin [13] . Indeed, calcium calmodulin antagonists such as trifluoperazine stimulate renin release from rat glomeruli [38], rat renal cortical slices [22] , isolated perfused rat kidneys [31, 65] and isolated juxtaglomerular cells [44] . However, we also found that trifluoperazine inhibited the transmembrane calcium influx into the juxtaglomerular cells, a fact that is also known from other tissues [66] . It is therefore difficult to decide from the experiments using calmodulin antagonists whether or not the inhibitory effect of calcium on renin release is mediated by calmodulin.
Role of Protein Kinase C Activity for the IntraceHular Control of Renin Release
As mentioned above, the secretory process in typical secreting ceils is initiated by a rise in the intracellular calcium concentration and is sustained by the activity of the protein kinase C. These subsequent intracellular events are usually caused by the activation of a plasma membrane bound phospholipase C (PLC) which splits polyphosphoinositides into inositolphosphates and diacylglycerol [7] . Activators of PLC such as angiotensin II in adrenal glomerulosa cells [64] are therefore typical stimuli for secretion in secretory ceils. Protein kinase C (PKC) is normally activated by diacylglycerol [54] and this effect can be mimicked by tumor promoting phorbol esters, such as 12-0-Tetradecanoylphorbol 13-Acetate (TPA) [11] . It is therefore possible to induce a sustained secretory response by the addition of TPA to cells.
We have shown that hormones activating PLC in isolated juxtaglomerular cells such as angiotensin II, arginine-vasopressin, norepinephrine and platelet activating factor strongly inhibit renin release from the cells [45, 61] . Since activation of PLC causes both calcium mobilisation and activation of PKC and since calcium mobilisation is considered as a strong inhibitory signal for renin release it is difficult to explore the role of PKC for renin release from these experiments. A direct stim- ulation of PKC activity can be achieved by tumor promoting phorbol esters such as TPA. TPA added either to isolated juxtaglomerular cells [45] or to renal cortical slices [23] leads to a dose-dependent inhibition of renin release from these preparations (Fig. 2) . A significant effect of TPA on renin release from both preparations, however, was only observed at rather high concentrations of TPA (10 .7 M). At high concentrations (10 .6 M) TPA is also suspected to act as a calcium ionophore independently of its activating effect on PKC [11] .
Since an enhanced calcium influx brought about by a calcium ionophore would be expected to inhibit renin release a direct inhibitory effect of TPA on renin release can therefore not be excluded. Churchill et al., however, reported that the inhibitory effect of TPA on renin release from kidney slices was not due to an ionophore effect [23] . We have found in this context that TPA also enhanced the transmembrane calcium influx into the isolated juxtaglomerular cells [45] . This calcium influx could be blocked by the calcium channel blocker verapamil. In parallel, verapamil also attenuated or even abolished the inhibitory effect of TPA on renin release. It is therefore not clear from our study whether TPA inhibits renin release by the phosphorylation of as yet unknown proteins via PKC activation or by enhancing the transmembrane calcium influx either dependent or independent of PKC activation.
Depite the uncertainty about the way by which TPA or protein kinase C inhibit renin release it can be inferred that activation of the protein kinase C does not stimulate the secretory process in the renal juxtaglomerular cells as it is typical for other secretory cells. Also in this regard the secretory mechanism in the juxtaglomerular cells seems to differ significantly from that of normal secretory cells.
Role of Cyclic AMP for the Intracellular Control of Renin Release
Activation of the adenylate cyclase is known as an important signal for the regulation of secretion in different types of secretory cells. In contrast to calcium the effect of cAMP on the secretion process is not uniform. As reviewed by Rassmussen and Barrett [64] cAMP can either enhance the secretory response (e.g. in pancreatic cells) or even decrease the secretory response (e.g. in platelets). The mechanism by which cAMP affects secretion in these cells has not been elucidated in detail but it seems likely that cAMP exerts its effect by the activation of cAMP dependent protein kinases [64] . Moreover there is growing evidence that cAMP affects the secretion process by interfering with calcium and PKC activity [64] .
With respect to the response to cAMP, the juxtaglomerular cells seem to behave like pancreatic or adrenal cells. In detail, there is broad evidence that substances activating the adenylate cyclase on the one hand, like fl-catecholamines [26, 39] , prostaglandins [34, 35, 82, 83] , glucagone [75, 78] , parathyroid hormone [63, 67] and on the other hand dibutyryl-cAMP [2, 52] all stimulate renin release. Furthermore, inhibition of cAMP phosphodiesterase also leads to a stimulation of renin release [60, 80] . These findings were obtained using perfused kidneys, incubated kidney slices, incubated renal glomeruli and isolated juxtaglomerular cells. Using isolated juxtaglomerular cells we could also show that activators of the adenylate cyclase like isoproterenol, prostacyclin or forskolin enhanced the cellular content of cAMP within the juxtaglomerular cells and stimulated renin release [441.
The question therefore arises by which mechanism cAMP stimulates renin release. And in particular it has to be discussed whether or not cAMP influences renin release by a direct effect or by a decrease of the intracellular calcium concentration. In isolated juxtaglomerular cells we obtained evidence that the rate of renin release was correlated to the intracellular level of cAMP in presence of activators of the adenylate cyclase (Fig. 3) . On the other hand an increase in the level of cAMP turned out not to be a prerequisite for the stimulation of renin release. In presence of the calcium channel blocker verapamil and the calmodulin an-tagonist trifluoperazine we observed an increase in the rate of renin release between 200-500% of control, a figure that is well comparable to the effect ofisoproterenol or prostacyclin (Fig. 3) . Verapamil and trifluoperazine, however, had no effect on the cellular cAMP level. Agents known to inhibit renin release such as angiotensin II on the other hand also failed to influence the cAMP level. We may conclude from these findings that cAMP is not the dominant regulator of renin release from juxtaglomerular cells.
It is evident therefore to discuss whether or not cAMP could stimulate renin release by affecting the intracellular concentration of calcium, in special by lowering this parameter. There are three pieces of experimental evidence to indicate that cAMP could stimulate renin release by lowering the intracellular concentration of calcium in juxtaglomerular cells. First, in experiments with isolated juxtaglomerular cells we have found that activators of the adenylate cyclase decrease the calcium permeability of the plasma membrane [44] . Second, it has been shown that the stimulatory effect of cAMP can be attenuated or even be abolished by increasing the intracellular concentration of calcium [19, 57, 77] . Third, it has been found for a variety of cells that cAMP is capable of stimulating Ca-ATPases as well as the sodium-calcium exchange mechanism [62, 76] . Both processes lead to a fall in the intracellular concentration of calcium. Taken together, there are arguments suggesting that cAMP and activators of the adenylate cyclase could stimulate renin release by lowering the intracellular calcium concentration. In this view cAMP would apparently influence the secretory process in juxtaglomerular cells in the same way as in other secretory cells. But the detailed mechanism by which cAMP acts on juxtaglomerular cells seems to be different from that of other secretory glands.
Role of Cyclic GMP for the Intracellular Control of Renin Release
The role of cGMP in the secretory process in general is only poorly understood. There are observations that stimulation of secretion from several cell types is accompanied by rises in intracellular cGMP levels [53] . The exact role of cGMP, however, in the secretory process is not known. Also, only very little information exists about the possible role of cGMP for the control of renin release from juxtaglomerular cells. Recently, a hormone has been discovered that is believed to act on its target cells by increasing the intracellular level of cGMP. This hormone is the atrial natriuretic peptide [5] and besides its natriuretic effect this hormone has also been found to inhibit renal renin release [9, 32, 50] . Since it was not clear whether atrial natriuretic peptide exerted its effect by a direct action on juxtaglomerular cells or indirectly by activating the macula densa receptor, studies were performed in which the effect of atrial natriuretic peptide on renin release from renal cortical slices [55] and from isolated juxtaglomerular cells [46] was investigated. Both studies revealed that atrial natriuretic peptide led to a dose-dependent inhibition of renin release from these preparations. Atrial natriuretic peptide also caused an enhanced release of cGMP from the perfused kidney and a decreased release of cAMP in the kidney [55] . Since it is known that atrial natriuretic peptide is capable of stimulating guanylate cyclase in the kidney [74] and simultaneously inhibiting adenylate cyclase in the kidney [3] , the question arose whether the inhibitory effect of atrial natriuretic peptide on renin relase was due to the rise in cGMP or to the decrease in cAMP. Using isolated juxtaglomerular cells we obtained clear evidence that the inhibition of renin release from the cells in presence of atrial natriuretic peptide was correlated with the level of cGMP and not with the level of cAMP [47] . Moreover we found that renin release from the isolated juxtaglomerular cells was inversely related to the cellular level of cGMP (Fig. 4) . From these findings it can be inferred that atrial natriuretic peptide inhibits renin release by rising the intracellular level of cGMP. This indicates that cGMP is an inhibitory signal in the control of renin release in juxtaglomerular cells.
As with cAMP again the question arises whether cGMP has a direct effect in the regulation of renin release or whether it acts indirectly by increasing the intracellular calcium concentration. We therefore measured the transmembrane calcium influx rate and the quin-2 signal of isolated juxtaglomerular cells in presence of atrial natriuretic peptide. However, we failed to detect any influence of atrial natriuretic peptide on either the transmembrane calcium influx or on the intracellular calcium concentration as monitored by the quin-2 signal [46]. It is likely therefore that the inhibitory role of cGMP on renal renin release does not involve an increase in the cytosolic calcium concentration.
Recently we have found that adenosine, which is known to inhibit renin release from whole kidneys and renal cortical slices, also inhibited renin release from isolated juxtaglomerular cells up to a concentration of 10 .6 M. At these concentra- tions of adenosine no significant alterations of transmembrane calcium influx and of the quin-2 signal could be detected. However, at these concentrations significant rises in intracellular cGMP were observed, whilst the concentration of cAMP was totally unchanged. This observation could be taken as a further support for the idea that cGMP could be a direct inhibitor of renin release in the renal juxtaglomerular cells.
It should be noted in this context that we found in isolated juxtaglomerular cells that the inhibitory effect of atrial natriuretic peptide on renin release was markedly attenuated in the presence of the calcium channel blocker verapamil [47] . Since we have found that verapamil also decreases the basal calcium influx into the cells [44, 45] , one could speculate from all of these findings that cGMP requires a normal calcium concentration to exert its maximal inhibitory effect on renin release. In summary, experimental evidence indicates that cGMP is an inhibitory signal for renin release from juxtaglomerular cells without affecting intracellular calcium concentration.
Conclusions
The present knowledge about the intracellular control of renin release is summarized in Fig. 5 .
The detailed mechanisms by which calcium, cGMP, cAMP and protein kinase C influence renin secretion from juxtaglomerular cells is not known so far. In general, calcium, and cyclic nucleotides are thought to exert their metabolic effects by the activation of specific protein kinases. Application of this concept on juxtaglomerular cells leads to the following model: Activation of a calcium dependent protein kinase, of cGMP dependent protein kinase and of the phospholipid dependent protein kinase C inhibit renin release. If one accepts that the rate of renin release is correlated to the rate of membrane fusions between renin granules and the plasma membrane [73] , then it could be speculated that these membrane fusions are inhibited by the activation of the protein kinases mentioned above. Activation of a cAMP dependent protein kinase on the other hand will stimulate renin release. This could mean that the membrane fusion between the renin granule and the plasma membrane is faciliated by the action of a cAMP dependent protein kinase. Another explanation could be that the activation of a cAMP dependent protein kinase results in a fall in the intracellular concentration of calcium which in turn would lead to an inactivation of the calcium dependent protein kinase. Inhibition of the inhibitory function of the calcium dependent protein kinase for renin release would then lead to a stimulation of renin secretion.
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